ES8101556A1 - Un procedimiento para la preparacion de derivados de imida- zol. - Google Patents
Un procedimiento para la preparacion de derivados de imida- zol.Info
- Publication number
- ES8101556A1 ES8101556A1 ES486782A ES486782A ES8101556A1 ES 8101556 A1 ES8101556 A1 ES 8101556A1 ES 486782 A ES486782 A ES 486782A ES 486782 A ES486782 A ES 486782A ES 8101556 A1 ES8101556 A1 ES 8101556A1
- Authority
- ES
- Spain
- Prior art keywords
- phenoxyalkyl
- imidazoles
- pharmaceutical compositions
- synthetase enzyme
- thromboxane synthetase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PROCEDIMIENTO DE OBTENCION DE DERIVADOS DE IMIDAZOL. CONSISTE EN HACER REACCIONAR IMIDAZOL CON UN HIDRURO DE METAL ALCALINO Y AÑADIR CON COMPUESTO DE FORMULA GENERAL (I). *FORMULA* SE OBTIENE UN COMPUESTO DE FORMULA GENERAL (II), SIENDO R: NO2, CN, SO2NH2; R ELEVADO A 1 ES H, ALQUILO C1-C4, ALCOXI C1-C4 O HALOGENO. INHIBICION DE LA ACCION DEL ENZIMA TROMBOXAMA-SINTETASA; INHIBICION DE LAS ENZIMAS PROSTACIDIN-SINTETASA O CICLO-OXIGENASA. TRATAMIENTO DE TROMBOSIS, ISQUIMIA, JAQUECA Y COMPLICACIONES VASCULARES DE DIABETES. T
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7848367 | 1978-12-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES486782A0 ES486782A0 (es) | 1980-12-16 |
ES8101556A1 true ES8101556A1 (es) | 1980-12-16 |
Family
ID=10501705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES486782A Expired ES8101556A1 (es) | 1978-12-13 | 1979-12-11 | Un procedimiento para la preparacion de derivados de imida- zol. |
Country Status (34)
Country | Link |
---|---|
US (2) | US4602016A (es) |
JP (1) | JPS585197B2 (es) |
KR (1) | KR830001243B1 (es) |
AR (1) | AR227637A1 (es) |
AT (1) | AT373879B (es) |
AU (1) | AU517892B2 (es) |
BE (1) | BE880584A (es) |
CA (1) | CA1108137A (es) |
CH (1) | CH644597A5 (es) |
CS (1) | CS216517B2 (es) |
DD (1) | DD147943A5 (es) |
DE (1) | DE2950019A1 (es) |
DK (1) | DK471479A (es) |
EG (1) | EG14227A (es) |
ES (1) | ES8101556A1 (es) |
FI (1) | FI70888C (es) |
FR (1) | FR2444031A1 (es) |
GB (1) | GB2038821B (es) |
GR (1) | GR73003B (es) |
HU (1) | HU183016B (es) |
IE (1) | IE49318B1 (es) |
IL (1) | IL58917A (es) |
IT (1) | IT1194900B (es) |
LU (1) | LU81985A1 (es) |
NL (1) | NL177749C (es) |
NO (1) | NO153135C (es) |
NZ (1) | NZ192360A (es) |
PH (1) | PH15056A (es) |
PL (1) | PL134005B1 (es) |
PT (1) | PT70571A (es) |
SE (1) | SE444937B (es) |
SU (1) | SU878195A3 (es) |
YU (1) | YU301879A (es) |
ZA (1) | ZA796708B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4350696A (en) * | 1980-03-08 | 1982-09-21 | Pfizer Inc. | Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof |
US4444775A (en) * | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
DE3148291A1 (de) * | 1981-12-05 | 1983-06-09 | Basf Ag, 6700 Ludwigshafen | Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
JPS58113178A (ja) * | 1981-12-28 | 1983-07-05 | Yamanouchi Pharmaceut Co Ltd | 「お」−(1−イミダゾリル)アルキルオキシ(またはチオ)ベンゼン誘導体 |
US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
NL8301550A (nl) * | 1983-05-03 | 1984-12-03 | Gist Brocades Nv | Imidazolethanol esters. |
US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
IT1212791B (it) * | 1983-11-24 | 1989-11-30 | Medea Res Srl | Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono. |
ES539074A0 (es) * | 1984-12-10 | 1985-11-16 | Ferrer Int | Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos. |
US4894385A (en) * | 1985-01-16 | 1990-01-16 | Sankyo Company Limited | Imidazole derivatives as inhibitors of TXA2 synthesis |
NO166644C (no) | 1986-01-28 | 1991-08-21 | Sankyo Co | Analogifremgangsmaate til fremstilling av tianaftenderivater. |
DE3786030T2 (de) | 1986-03-27 | 1993-12-02 | Merck Frosst Canada Inc | Tetrahydrocarbazole Ester. |
JPS63179840A (ja) * | 1986-07-24 | 1988-07-23 | Yamanouchi Pharmaceut Co Ltd | 新規化学物質 |
EP0284892B1 (de) * | 1987-04-03 | 1990-10-31 | Cl Pharma Aktiengesellschaft | Neue 2-Thienyloxyessigsäurederivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
JPH01125372A (ja) * | 1988-09-12 | 1989-05-17 | Yamanouchi Pharmaceut Co Ltd | イミダゾリルアルキルオキシベンゼン誘導体 |
DE4204686A1 (de) * | 1992-02-17 | 1993-08-19 | Gruenenthal Gmbh | Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln |
AU2890899A (en) * | 1998-03-13 | 1999-09-27 | Pozen, Inc. | Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists |
ES2172436B1 (es) | 2000-10-31 | 2004-01-16 | Almirall Prodesfarma Sa | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
JP2005533830A (ja) * | 2002-07-09 | 2005-11-10 | ビー.エム.アール.エイ. コーポレイション ベスローテン フェンノートシャップ | トロンボキサンa2受容体アンタゴニストおよびcox−2阻害剤の薬剤の組み合わせ |
CA2534316A1 (en) * | 2003-08-07 | 2005-02-24 | B.M.R.A. Corporation B.V. | Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxygenase-1 |
KR101275814B1 (ko) * | 2006-06-23 | 2013-06-18 | 삼성에스디아이 주식회사 | 분산제 화합물 및 그의 제조방법 |
EP2543368A1 (en) | 2007-12-11 | 2013-01-09 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
CN101811974B (zh) * | 2010-04-15 | 2012-12-12 | 合肥医工医药有限公司 | 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途 |
CN101851209B (zh) * | 2010-06-21 | 2012-09-19 | 合肥医工医药有限公司 | 咪唑乙基香草酸醚、其制备方法及其医药用途 |
EA026393B1 (ru) * | 2012-05-22 | 2017-04-28 | Дженентек, Инк. | N-замещенные бензамиды и их применение в лечении боли |
RU2015119640A (ru) | 2012-10-26 | 2016-12-20 | Мерк Шарп И Доум Корп. | Соединения n-замещенного индазол-сульфонамида с избирательной активностью в потенциал-зависимых натриевых каналах |
CN114736161B (zh) * | 2022-06-13 | 2022-09-13 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
WO2023240378A1 (zh) * | 2022-06-13 | 2023-12-21 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3534061A (en) * | 1967-12-04 | 1970-10-13 | Parke Davis & Co | N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles |
US4085209A (en) * | 1975-02-05 | 1978-04-18 | Rohm And Haas Company | Preparation and safening effect of 1-substituted imidazole metal salt complexes |
US4078071A (en) * | 1976-03-08 | 1978-03-07 | Syntex (U.S.A.) Inc. | Derivatives of substituted N-alkyl imidazoles |
JPS5951943B2 (ja) * | 1978-08-21 | 1984-12-17 | キツセイ薬品工業株式会社 | 新規なイミダゾ−ル誘導体 |
-
1979
- 1979-11-07 DK DK471479A patent/DK471479A/da not_active Application Discontinuation
- 1979-11-19 US US06/095,755 patent/US4602016A/en not_active Expired - Lifetime
- 1979-12-10 AR AR279215A patent/AR227637A1/es active
- 1979-12-10 GB GB7942535A patent/GB2038821B/en not_active Expired
- 1979-12-11 IT IT41669/79A patent/IT1194900B/it active
- 1979-12-11 PT PT70571A patent/PT70571A/pt unknown
- 1979-12-11 GR GR60727A patent/GR73003B/el unknown
- 1979-12-11 HU HU79PI699A patent/HU183016B/hu unknown
- 1979-12-11 ES ES486782A patent/ES8101556A1/es not_active Expired
- 1979-12-11 NZ NZ192360A patent/NZ192360A/xx unknown
- 1979-12-11 FI FI793868A patent/FI70888C/fi not_active IP Right Cessation
- 1979-12-11 ZA ZA00796708A patent/ZA796708B/xx unknown
- 1979-12-11 SE SE7910204A patent/SE444937B/sv unknown
- 1979-12-11 IL IL58917A patent/IL58917A/xx unknown
- 1979-12-11 YU YU03018/79A patent/YU301879A/xx unknown
- 1979-12-11 NL NLAANVRAGE7908899,A patent/NL177749C/xx not_active IP Right Cessation
- 1979-12-12 CA CA341,691A patent/CA1108137A/en not_active Expired
- 1979-12-12 FR FR7930438A patent/FR2444031A1/fr active Granted
- 1979-12-12 DE DE19792950019 patent/DE2950019A1/de not_active Ceased
- 1979-12-12 EG EG743/79A patent/EG14227A/xx active
- 1979-12-12 CS CS798708A patent/CS216517B2/cs unknown
- 1979-12-12 SU SU792854456A patent/SU878195A3/ru active
- 1979-12-12 AT AT0783379A patent/AT373879B/de not_active IP Right Cessation
- 1979-12-12 LU LU81985A patent/LU81985A1/fr unknown
- 1979-12-12 JP JP54161382A patent/JPS585197B2/ja not_active Expired
- 1979-12-12 IE IE2403/79A patent/IE49318B1/en unknown
- 1979-12-12 KR KR1019790004397A patent/KR830001243B1/ko active
- 1979-12-12 BE BE0/198542A patent/BE880584A/fr not_active IP Right Cessation
- 1979-12-12 PL PL1979220351A patent/PL134005B1/pl unknown
- 1979-12-12 NO NO794069A patent/NO153135C/no unknown
- 1979-12-12 AU AU53725/79A patent/AU517892B2/en not_active Ceased
- 1979-12-13 PH PH23412A patent/PH15056A/en unknown
- 1979-12-13 DD DD79217645A patent/DD147943A5/de unknown
- 1979-12-13 CH CH1106279A patent/CH644597A5/de not_active IP Right Cessation
-
1985
- 1985-03-21 US US06/714,422 patent/US4636500A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8101556A1 (es) | Un procedimiento para la preparacion de derivados de imida- zol. | |
ES8104278A1 (es) | Un procedimiento para la preparacion de derivados del indol. | |
ES8101557A1 (es) | Un procedimiento para la preparacion de derivados de imida- zol. | |
HUT67436A (en) | Process to prepare novel hydroxamic acid and n-hydroxyurea derivatives and pharmaceutical compn.s contg. them | |
DK155143C (da) | Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet | |
MY133647A (en) | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | |
MY110104A (en) | Saccharin derivative proteolytic enzyme inhibitors | |
ES8307744A1 (es) | Un metodo para la preparacion de nuevos derivados de sales de metales alcalinos de acidos 2-pirrolidon-4-carboxilicos. | |
IL122401A0 (en) | Anti-inflammatory compositions | |
MD1688G2 (ro) | Benzotiofen, benzofuran şi indoltiazepinone, oxazepinone şi diazepinone, compoziţie farmaceutică, metodă de inhibare a aderării leucocitelor la celulele endoteliale pentru tratamentul proceselor inflamatorii şi metodă de tratament al mamiferelor infectate cu HIV infecţie . | |
ES486279A1 (es) | Procedimiento para la obtencion de hidroxipropil-triazoles | |
FR1234879A (fr) | Perfectionnements apportés aux produits pour l'extermination des animaux nuisibles et aux procédés pour préparer des anhydrides et des amides d'acides o, o-dialcoyldithiophosphoryl-gras utilisables comme matières actives dans ces produits | |
ES438931A1 (es) | Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano. | |
GB1335783A (en) | Anti-seborrhoeic compositions | |
ATE321045T1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
DK0413793T3 (da) | Koncentrerede vandige emulsioner, en fremgangsmåde til deres fremstilling og deres anvendelse på pesticidområdet | |
ES451880A1 (es) | Procedimiento de preparacion de una nueva composicion den- tifrica. | |
ATE110714T1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
ID26240A (id) | Formulasi obat setengah padat yang mengandung dekstoprofen trometamol | |
ES447307A1 (es) | Procedimiento para la preparacion de una 1-(alfa-sustituida--aminoacil)-3-desoxirribostamicina. | |
IT1209419B (it) | Composti ad attivita' mucolitica non assimilabili, processo per laloro preparazione e composizioni terapeutiche che li comprendono come principio attivo. | |
ES269442A1 (es) | Procedimiento de preparaciën de orotato de lisina | |
FR2455610A1 (fr) | Nouveaux steroides inhibiteurs de la 5a-reductase, utiles notamment pour le traitement de l'acne et leur procede de preparation | |
FR2113947A1 (en) | Oral raubasine compositions - also contg polyethylene glycol to improve resorption | |
ES419165A1 (es) | Un metodo de preparar una formulacion farmaceutica que in- cluye un 3-amino-prop-1-eno sustituido. |